Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoko Hirakata is active.

Publication


Featured researches published by Tomoko Hirakata.


Surgery Today | 2013

Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer

Sayaka Yamaki; Takaaki Fujii; Reina Yajima; Tomoko Hirakata; Satoru Yamaguchi; Tomomi Fujisawa; Soichi Tsutsumi; Takayuki Asao; Yasuhiro Yanagita; Misa Iijima; Hiroyuki Kuwano

PurposeGalectin-3 expression is modulated in cancer cells, and that finding has led to the recognition of galectin-3 as a diagnostic or prognostic marker for various cancers, including breast cancer. This study investigated the correlation between galectin-3 expression and the clinicopathological features in patients with breast cancer, in order to determine the relevance and role of galectin-3 in breast cancer progression.MethodsGalectin-3 expression was investigated immunohistochemically in 116 patients with breast cancer, and a statistical analysis was performed.ResultsGalectin-3 expression in breast cancer was significantly associated with tumor vascular invasion. However, galectin-3 expression was not associated with Ki-67 expression, which reflects tumor proliferation. Disease-free survival and long-term overall survival were significantly shorter for patients with reduced galectin-3 expression.ConclusionsThis study demonstrated that the galectin-3 expression was associated with tumor vascular invasion and metastasis, suggesting that galectin-3 plays a critical role in tumor progression via an invasive mechanism but not via proliferation in breast cancer. Furthermore, reduced expression of galectin-3 is useful for predicting a long-term poor prognosis in patients with breast cancer.


Tumori | 2011

Accuracy of intraoperative macroscopic diagnosis of sentinel node metastases in breast cancer: is accurate prediction possible?

Takaaki Fujii; Yasuhiro Yanagita; Teruhiko Kinoshita; Tomomi Fujisawa; Tomoko Hirakata; Sayaka Yamaki; Asuka Matsumoto; Nobuyuki Uchida; Misa Iijima; Hiroyuki Kuwano

Background Accurate intraoperative diagnosis of sentinel lymph node (SLN) metastases enables the selection of patients who require axillary lymph node dissection, thus avoiding an additional operation. In this study we investigated the accuracy of intraoperative macroscopic diagnosis of SLN metastases in patients with breast cancer. Methods SLNs from 276 breast cancer patients with clinically negative nodes were analyzed by macroscopic examination. The results of intraoperative macroscopic diagnosis were compared with those of frozen section analysis. Results The sensitivity, specificity, overall accuracy, and false negative rate of SLN biopsy in the assessment of node status were 82.1%, 100%, 96.4%, and 17.9%, respectively, for frozen section analysis, and 57.1%, 95.5%, 87.7%, and 42.9%, respectively, for macroscopic evaluation. Even in patients with node metastasis >7 mm, the false negative rate of macroscopic evaluation was 11.1%. Conclusions Our results suggest that macroscopic diagnosis is less effective in predicting lymph node status in breast cancer than frozen section analysis. These findings imply that intraoperative macroscopic evaluation of sentinel nodes is never predictive of the final pathology. Free full text available at www.tumorionline.it


Pediatrics International | 2006

Bilateral ovarian teratomas successfully treated by ovary-conserving technique

Hayato Yamauchi; Atsushi Takahashi; Tomoko Hirakata; Kazumichi Onigata; Takashi Kanazawa; Chitose Ogawa; Minoru Kuroiwa; Akihiro Morikawa; Hiroyuki Kuwano

Correspondence: Hayato Yamauchi, Department of General Surgical Science, Gunma University, Graduate School of Medicine, 3 – 39 – 22 Showa-machi, Maebashi, Gunma 371 – 8511, Japan. Received 1 June 2004; accepted 9 February 2005. Benign or malignant teratomas are the most common ovarian neoplasms in adolescents. There have been some discussions about treatment strategies for these tumors, especially bilateral ovarian teratomas. 1 Moreover, surgical therapy of the ovarian teratoma has also been controversial, and the method ranges from an ovary-conserving operation to ovariosalpingectomy. 2 – 7


Annals of Surgical Oncology | 2015

Prognostic Value of Extracapsular Invasion of Axillary Lymph Nodes Combined with Peritumoral Vascular Invasion in Patients with Breast Cancer

Reina Yajima; Takaaki Fujii; Yasuhiro Yanagita; Tomomi Fujisawa; Takeshi Miyamoto; Tomoko Hirakata; Soichi Tsutsumi; Misa Iijima; Hiroyuki Kuwano

BackgroundExtracapsular invasion (ECI) of metastatic axillary lymph nodes has been associated with aggressive nodal disease but its prognostic role in breast cancer is unclear. The present study evaluated nodal ECI as a predictor of breast cancer recurrence.MethodsWe evaluated 154 women with histologically proven node-positive breast cancer who were diagnosed with invasive ductal carcinoma, and investigated the relationships between ECI and recurrences and other clinicopathological factors, particularly vascular invasion and the number of lymph node metastases.ResultsThe presence of ECI at positive nodes was significantly associated with the number of positive nodes, and with disease recurrence and survival in univariate (but not multivariate) analysis. Interestingly, all ECI+ patients with distant metastases in our series had peritumoral vascular invasion (PVI), which may have reflected systemic disease; ECI with PVI of the primary tumor strongly predicted recurrent disease and shorter survival.ConclusionECI of axillary metastases combined with PVI indicates high tumor aggressiveness. Patients with ECI and PVI may be considered for stronger adjuvant therapies because of their high risk for distant recurrences.


International Surgery | 2014

Single-incision laparoscopic surgery for a small-intestinal gastrointestinal stromal tumor: report of a case.

Makoto Sakai; Wataru Wada; Shintaro Kimura; Akiko Okada; Tomoko Hirakata; Ryoichi Onozato; Kana Saito; Koji Morohara; Hidenobu Osawa; Kazuhisa Katayama; Naokuni Yasuda; Shigebumi Tanaka; Hiroyuki Kuwano

Our report concerns a 64-year-old man with a small-intestinal gastrointestinal stromal tumor (GIST), which was successfully treated with single-incision laparoscopic surgery (SILS). Small-bowel endoscopy detected a submucosal tumor located approximately 10 cm from the ligament of Treitz in the wall of the proximal jejunum. Contrast-enhanced computed tomography revealed a tumor (diameter, 4 cm) containing high- and low-density areas in the proximal jejunum. On 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET), the tumor demonstrated intense FDG uptake (maximum standard uptake value, 3.82), whereas it displayed high signal intensity on diffusion-weighted magnetic resonance images. No metastatic lesions were observed. The patient was diagnosed with a jejunal GIST. Wedge resection of the jejunum was performed using the SILS procedure. The tumor was histopathologically diagnosed as a low-grade malignant GIST. SILS is a useful resection technique for small-intestinal GIST.


Anticancer Research | 2018

Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer

Takaaki Fujii; Keiko Yanai; Shoko Tokuda; Yuko Nakazawa; Sasagu Kurozumi; Sayaka Obayashi; Reina Yajima; Tomoko Hirakata; Ken Shirabe

Background: 18F-Fluorodeoxyglucose-positron-emission tomography (FDG-PET) is used to evaluate the glucose metabolic rates of tumors. Several studies have reported that high FDG uptake is predictive of poor prognosis and aggressive features in patients with breast cancer. FDG uptake is influenced by many factors, including inflammation. In this study, the relationship between FDG uptake and neutrophil/lymphocyte ratio (NLR), which is an indicator of systemic inflammation, was investigated. Patients and Methods: A retrospective investigation of the cases of 143 consecutive patients with invasive ductal carcinoma who had undergone surgery and FDG-PET preoperatively. PET was evaluated using standardized uptake value max (SUVmax). The median SUVmax was 2.5 (range=0-10.5). The cases were divided into two groups based on the value of SUVmax: low (<2.5) and high (≥2.5). The relationships between SUVmax and clinicopathological features, including NLR, were investigated. Results: Among the 143 patients, 73 (51.0%) had high SUVmax in the primary tumor. The analysis revealed that large tumor size (p<0.001), high nuclear grade (p<0.001), the presence of lymphovascular invasion (p<0.001), high C-reactive protein (p=0.046) and high NLR (p<0.001) were significantly associated with high SUVmax in the primary tumor. SUVmax and NLR were significantly positively correlated (r=0.323, p<0.001). Among the 70 cases with low SUVmax, there was no recurrent disease, while out of the 73 cases with high SUVmax had disease recurrence. It is interesting to note that the group with high SUVmax and low NLR had no recurrent disease. Conclusion: The present study demonstrated that the finding of high preoperative FDG uptake in breast cancer may be reflective of poor prognosis and that a high NLR may be predictive of aggressive features among patients with breast cancer. On the other hand, among patients with breast cancer with high SUVmax in the primary tumor, it will be useful to identify those with a low NLR in order to improve prognostic accuracy.


World Journal of Surgery | 2010

Implication of Extracapsular Invasion of Sentinel Lymph Nodes in Breast Cancer: Prediction of Nonsentinel Lymph Node Metastasis

Takaaki Fujii; Yasuhiro Yanagita; Tomomi Fujisawa; Tomoko Hirakata; Misa Iijima; Hiroyuki Kuwano


Breast Cancer | 2013

The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer

Tomomi Fujisawa; Tomoko Hirakata; Yasuhiro Yanagita; Misa Iijima; Hiroyuki Horikoshi; Koji Takeuchi; Yumi Saitoh


Anticancer Research | 2014

Impact of the Prognostic Value of Vascular Invasion, but Not Lymphatic Invasion, of the Primary Tumor in Patients with Breast Cancer

Takaaki Fujii; Reina Yajima; Tomoko Hirakata; Takeshi Miyamoto; Tomomi Fujisawa; Soichi Tsutsumi; Yasuhiro Ynagita; Misa Iijima; Hiroyuki Kuwano


Anticancer Research | 2014

Early Predictive Value of Non-response to Docetaxel in Neoadjuvant Chemotherapy in Breast Cancer Using 18F-FDG-PET

Tomoko Hirakata; Yasuhiro Yanagita; Tomomi Fujisawa; Takaaki Fujii; Teruhiko Kinoshita; Hiroyuki Horikoshi; Nariyuki Oya; Tsukasa Akiyoshi; Misa Iijima; Takeshi Miyamoto; Hiroyuki Kuwano

Collaboration


Dive into the Tomoko Hirakata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge